Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49


Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling.

Fillmore CM, Gupta PB, Rudnick JA, Caballero S, Keller PJ, Lander ES, Kuperwasser C.

Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21737-42. doi: 10.1073/pnas.1007863107. Epub 2010 Nov 22.


PMA-induced up-regulation of TBX3 is mediated by AP-1 and contributes to breast cancer cell migration.

Mowla S, Pinnock R, Leaner VD, Goding CR, Prince S.

Biochem J. 2011 Jan 1;433(1):145-53. doi: 10.1042/BJ20100886.


Tbx3 improves the germ-line competency of induced pluripotent stem cells.

Han J, Yuan P, Yang H, Zhang J, Soh BS, Li P, Lim SL, Cao S, Tay J, Orlov YL, Lufkin T, Ng HH, Tam WL, Lim B.

Nature. 2010 Feb 25;463(7284):1096-100. doi: 10.1038/nature08735. Epub 2010 Feb 7.


A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells.

Niwa H, Ogawa K, Shimosato D, Adachi K.

Nature. 2009 Jul 2;460(7251):118-22. doi: 10.1038/nature08113.


Tbx3 represses E-cadherin expression and enhances melanoma invasiveness.

Rodriguez M, Aladowicz E, Lanfrancone L, Goding CR.

Cancer Res. 2008 Oct 1;68(19):7872-81. doi: 10.1158/0008-5472.CAN-08-0301.


Mammary development in the embryo and adult: a journey of morphogenesis and commitment.

Watson CJ, Khaled WT.

Development. 2008 Mar;135(6):995-1003. doi: 10.1242/dev.005439. Review.


TBX3 is overexpressed in breast cancer and represses p14 ARF by interacting with histone deacetylases.

Yarosh W, Barrientos T, Esmailpour T, Lin L, Carpenter PM, Osann K, Anton-Culver H, Huang T.

Cancer Res. 2008 Feb 1;68(3):693-9. doi: 10.1158/0008-5472.CAN-07-5012.


Cooperation of signalling pathways in embryonic mammary gland development.

Robinson GW.

Nat Rev Genet. 2007 Dec;8(12):963-72. Review. Erratum in: Nat Rev Genet. 2008 Jul;9(7):566.


Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer.

Renard CA, Labalette C, Armengol C, Cougot D, Wei Y, Cairo S, Pineau P, Neuveut C, de Reyniès A, Dejean A, Perret C, Buendia MA.

Cancer Res. 2007 Feb 1;67(3):901-10.


TBX3, the gene mutated in ulnar-mammary syndrome, promotes growth of mammary epithelial cells via repression of p19ARF, independently of p53.

Platonova N, Scotti M, Babich P, Bertoli G, Mento E, Meneghini V, Egeo A, Zucchi I, Merlo GR.

Cell Tissue Res. 2007 May;328(2):301-16. Epub 2007 Jan 30.


Molecular interactions between Tbx3 and Bmp4 and a model for dorsoventral positioning of mammary gland development.

Cho KW, Kim JY, Song SJ, Farrell E, Eblaghie MC, Kim HJ, Tickle C, Jung HS.

Proc Natl Acad Sci U S A. 2006 Nov 7;103(45):16788-93. Epub 2006 Oct 27.


Ulnar-mammary syndrome with dysmorphic facies and mental retardation caused by a novel 1.28 Mb deletion encompassing the TBX3 gene.

Klopocki E, Neumann LM, Tönnies H, Ropers HH, Mundlos S, Ullmann R.

Eur J Hum Genet. 2006 Dec;14(12):1274-9. Epub 2006 Aug 9.


Dissecting self-renewal in stem cells with RNA interference.

Ivanova N, Dobrin R, Lu R, Kotenko I, Levorse J, DeCoste C, Schafer X, Lun Y, Lemischka IR.

Nature. 2006 Aug 3;442(7102):533-8. Epub 2006 Jun 11.


Nuclear factor-kappaB in cancer development and progression.

Karin M.

Nature. 2006 May 25;441(7092):431-6. Review.


Key stages in mammary gland development: the cues that regulate ductal branching morphogenesis.

Sternlicht MD.

Breast Cancer Res. 2006;8(1):201. Epub 2005 Dec 5. Review.


Generation of a functional mammary gland from a single stem cell.

Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat ML, Wu L, Lindeman GJ, Visvader JE.

Nature. 2006 Jan 5;439(7072):84-8.


Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells.

Eddy SF, Guo S, Demicco EG, Romieu-Mourez R, Landesman-Bollag E, Seldin DC, Sonenshein GE.

Cancer Res. 2005 Dec 15;65(24):11375-83.


Tbx3, the ulnar-mammary syndrome gene, and Tbx2 interact in mammary gland development through a p19Arf/p53-independent pathway.

Jerome-Majewska LA, Jenkins GP, Ernstoff E, Zindy F, Sherr CJ, Papaioannou VE.

Dev Dyn. 2005 Dec;234(4):922-33.


Increased expression of cSHMT, Tbx3 and utrophin in plasma of ovarian and breast cancer patients.

Lomnytska M, Dubrovska A, Hellman U, Volodko N, Souchelnytskyi S.

Int J Cancer. 2006 Jan 15;118(2):412-21.


Supplemental Content

Support Center